Tools
Tools
Craig, Neil J., Loganath, Krithika, Everett, Russell J., Bing, Rong, Ramtoola, Tariq, Tsampasian, Vasiliki, Molek, Patrycja, Botezatu, Simona, Aslam, Saadia, Macgillivray, Tom, Tuck, Christopher E., Rayson, Phillip, Calvert, Patrick A., Berry, Colin, Chin, Calvin W.L., Hillis, Graham S., Fairbairn, Timothy, Greenwood, John P., Steeds, Richard, Leslie, Stephen J., Lang, Chim C., Bucciarelli-Ducci, Chiara, Joshi, Nikhil V., Kunadian, Vijay, Prendergast, Bernard, Mills, Nicholas L., Vassiliou, Vassilios S. 
ORCID: https://orcid.org/0000-0002-4005-7752, Dungu, Jason N., Hothi, Sandeep S., Boon, Nicholas, Prasad, Sanjay K., Keenan, Niall G., Dawson, Dana, Motwani, Manish, Miller, Christopher A., Rajani, Ronak, Ripley, David P., Treibel, Thomas A., Mccann, Gerry P., Singh, Anvesha, Newby, David E. and Dweck, Marc R.
(2026)
Myocardial Fibrosis and Early Intervention in Asymptomatic Patients With Severe Aortic Stenosis:Insights From the EVOLVED Randomized Clinical Trial.
JAMA Cardiology, 11 (6).
pp. 599-605.
ISSN 2380-6583
Preview |
PDF (EVOLVED_Fibrosis_Burden_Brief_Report_R2_Clean_Version)
- Accepted Version
Available under License Creative Commons Attribution. Download (709kB) | Preview |
Abstract
Importance: Myocardial fibrosis burden has been associated with adverse clinical outcomes in symptomatic patients with aortic stenosis. Objective: To determine whether midwall myocardial fibrosis burden is associated with adverse clinical outcomes in asymptomatic patients and whether those with more fibrosis derive greater benefit from early intervention. Design, Setting, and Participants: This post hoc analysis of a randomized clinical trial was conducted between August 2017 and October 2022. The trial took place at 24 cardiac centers across the United Kingdom and Australia. Participants included asymptomatic patients with severe aortic stenosis and midwall fibrosis on cardiac magnetic resonance. These data were analyzed from October 2024 through June 2025. Intervention: Early intervention with transcatheter or surgical aortic valve replacement. Main Outcomes and Measures: Primary outcome was all-cause death or unplanned aortic stenosis-related hospitalization. Secondary outcomes included the individual components of the primary outcome. Results: In 224 trial participants (mean [SD] age, 73 [9] years; 63 women and 161 men, and mean [SD] aortic valve peak velocity 4.3 [0.5] m per second) with a median follow-up of 42 months, fibrosis burden (per 1% increase) was associated with an increase in the primary end point (hazard ratio [HR], 1.23; 95% CI, 1.08-1.37) and its component of unplanned aortic stenosis-related hospitalizations (HR, 1.22; 95% CI, 1.03-1.40) but not all-cause death (HR, 1.17; 95% CI, 0.98-1.35). There were no interactions between randomization arm and the midwall fibrosis burden for the primary (P for interaction =.39) or secondary end points. In patients with high fibrosis burden above the median, the primary end point occurred in 12 of 59 (20%) of those randomized to early intervention and 17 of 53 (32%) of those randomized to guideline-directed conservative management (HR, 0.62; 95% CI, 0.29-1.28). For the individual components, all-cause death occurred in 9 (15%) and 10 (19%) patients, respectively (HR, 0.84; 95% CI, 0.33-2.07), and unplanned aortic stenosis-related hospitalization in 4 (7%) and 13 (25%) patients respectively (HR, 0.27; 95% CI, 0.08-0.77). In patients with low fibrosis burden below the median, there were no differences in the primary outcome (HR, 1.05; 95% CI, 0.39-2.86) or its components between intervention groups. Conclusions and Relevance: In this study, in asymptomatic patients with severe aortic stenosis, higher midwall fibrosis burden was associated with adverse outcomes. There was no demonstrable heterogeneity by the degree of midwall fibrosis for the treatment effects of early surgical or transcatheter aortic valve replacement compared to clinical surveillance.
| Item Type: | Article |
|---|---|
| Additional Information: | Publisher Copyright: © 2026 American Medical Association. |
| Uncontrolled Keywords: | cardiology and cardiovascular medicine ,/dk/atira/pure/subjectarea/asjc/2700/2705 |
| Faculty \ School: | Faculty of Medicine and Health Sciences > Norwich Medical School |
| UEA Research Groups: | Faculty of Medicine and Health Sciences > Research Centres > Metabolic Health Faculty of Science > Research Groups > Norwich Epidemiology Centre Faculty of Medicine and Health Sciences > Research Groups > Norwich Epidemiology Centre Faculty of Medicine and Health Sciences > Research Groups > Cardiovascular and Metabolic Health |
| Related URLs: | |
| Depositing User: | LivePure Connector |
| Date Deposited: | 15 Jul 2026 15:39 |
| Last Modified: | 16 Jul 2026 01:17 |
| URI: | https://ueaeprints.uea.ac.uk/id/eprint/103865 |
| DOI: | 10.1001/jamacardio.2026.0654 |
Downloads
Downloads per month over past year
Actions (login required)
 |
View Item |